Fortis Advisors, LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Fortis Advisors, LLC

  • $127 Million
  • Q2 2024

A detailed history of Fortis Advisors, LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Fortis Advisors, LLC holds 5,300 shares of XBI stock, worth $516,803. This represents 0.39% of its overall portfolio holdings.

Number of Shares
5,300
Previous 4,150 27.71%
Holding current value
$516,803
Previous $393,000 24.94%
% of portfolio
0.39%
Previous 0.3%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024
BUY
$82.22 - $94.12 $94,553 - $108,238
1,150 Added 27.71%
5,300 $491,000
Q3 2022

Nov 10, 2022
BUY
$75.06 - $94.9 $37,530 - $47,450
500 Added 13.7%
4,150 $329,000
Q2 2022

Aug 15, 2022
BUY
$62.81 - $96.09 $40,826 - $62,458
650 Added 21.67%
3,650 $271,000
Q1 2022

May 16, 2022
BUY
$81.07 - $115.44 $243,209 - $346,320
3,000 New
3,000 $270,000

Others Institutions Holding XBI

# of Institutions
893
Shares Held
94.6M
Call Options Held
18.4M
Put Options Held
31.6M
View Full List

About SPDR SER TR SPDR S&P BIOTECH E

XBI Quotes by TradingView
  • Ticker XBI
  • Sector ETFs
  • Industry ETFs
More about XBI
Track This Portfolio

Track Fortis Advisors, LLC Portfolio

Follow Fortis Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fortis Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email